Darwin Global Management, Ltd. 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
DG Darwin Global Management, Ltd. | Institutional Filer | ▼ 23.66% | $3.77B | 6 |
Current Portfolio Holdings
Showing all 6 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Incorporated | Healthcare | 16.8M | $2.58B | 68.33% |
| 2 | BLTE | Belite Bio, Inc | Healthcare | 3.1M | $456.1M | 12.10% |
| 3 | ABVX | Abivax S.A. | Healthcare | 3.5M | $352.1M | 9.34% |
| 4 | RVMD | Revolution Medicines, Inc. | Healthcare | 2.2M | $205.0M | 5.44% |
| 5 | ROIV | Roivant Sciences Ltd. | Healthcare | 6.8M | $179.5M | 4.76% |
| 6 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 17K | $1.5M | 0.04% |
Showing 1 to 6 of 6 holdings